What is Evolution Devices?
Evolution Devices is at the forefront of developing assistive technology for individuals with neurological impairments. Their flagship product, the EvoWalk, is a wearable device employing Functional Electrical Stimulation (FES) to address foot drop. By stimulating key muscles, the EvoWalk aids in improving ankle and knee movement, thereby enhancing a user's walking ability, confidence, and independence. The company targets a critical patient demographic, including those recovering from strokes and individuals managing conditions like multiple sclerosis, offering personalized therapy and progress tracking via a dedicated mobile application. The EvoWalk's design prioritizes both comfort and therapeutic effectiveness, aiming to significantly improve the quality of daily life for its users.
How much funding has Evolution Devices raised?
Evolution Devices has raised a total of $52K across 1 funding round:
Debt
$52K
Debt (2021): $52K with participation from PPP
What's next for Evolution Devices?
With the recent influx of substantial expansion capital, Evolution Devices is poised for significant growth and scaling. This funding is expected to accelerate product development, enhance manufacturing capabilities, and broaden market reach. The company's strategic focus on FES technology for mobility restoration positions it to capture a growing market share in the assistive technology and rehabilitation sectors. Future investments will likely concentrate on clinical validation, expanding distribution channels, and further refining the EvoWalk's features based on user feedback and technological advancements. The company's trajectory suggests a strong emphasis on innovation and market penetration within the neurorehabilitation space.
See full Evolution Devices company page
